ACE2 and infection: Many vaccines against SARS-CoV-2 have been developed; all candidates try to achieve immunity to the virus, mainly directing the immune response to surface spike protein which binds to the host cell receptor angiotensin-converting enzyme 2 (ACE2), mediating viral cell entry and infection [2].